BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3347093)

  • 21. [Clinical effects of low-dose Ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes].
    Kanamori H; Maruta A; Fukawa H; Harano H; Kodama F; Miyashita H; Matsuzaki M; Noguchi T; Murata T; Hashimoto Y
    Rinsho Ketsueki; 1991 Feb; 32(2):108-14. PubMed ID: 2027236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes.
    Tambone Reyes M; Bonaccorso R; Gebbia V; Tinnirello D; Di Salvo V; Ciulla A; Di Marco P; Mansueto S; Citarrella P
    J Chemother; 1989 Jul; 1(4 Suppl):1276-8. PubMed ID: 16312864
    [No Abstract]   [Full Text] [Related]  

  • 23. Low dose cytosine arabinoside in refractory anemia with excess of blasts in transformation.
    Fridrik MA; Wahl G; Herbinger W
    Blut; 1988 Dec; 57(6):357-60. PubMed ID: 3207893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes].
    García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F
    Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline.
    Fukushima T; Kawabata H; Sawaki T; Satoh T; Nakamura T; Iwao H; Nakajima A; Sakai T; Miki M; Fujita Y; Tanaka M; Kawanami T; Masaki Y; Okazaki T; Umehara H
    Anticancer Res; 2012 Apr; 32(4):1347-53. PubMed ID: 22493369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myelodysplastic syndrome. A clinical and pathological analysis of 88 patients.
    Nair R; Iyer RS; Nair CN; Kurkure PA; Pai SK; Saikia TK; Nadkarni KS; Pai VR; Gopal R; Advani SH
    Indian J Cancer; 1993 Dec; 30(4):169-75. PubMed ID: 8206499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral idarubicin as treatment for advanced myelodysplastic syndrome.
    Lowenthal RM; Lambertenghi-Deliliers G
    Haematologica; 1991; 76(5):398-401. PubMed ID: 1806444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment with cytosine arabinoside and granulocyte colony-stimulating factor in patients with myelodysplastic syndrome and its leukemic phase.
    Im T; Yamane T; Mugitani A; Hiyoshi M; Park K; Tatsumi N
    Int J Hematol; 1994 Oct; 60(3):215-23. PubMed ID: 7532031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): results of an interim analysis.
    Okamoto T; Kanamaru A; Shimazaki C; Motoji T; Takemoto Y; Takahashi M; Fukushima T; Takeshita A; Kusumoto GS; Kishimoto Y; Yorimitsu S; Tsukuda K; Uike N; Arima N; Ohno R
    Int J Hematol; 2000 Aug; 72(2):200-5. PubMed ID: 11039669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Five cases of de novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) achieved CR with the continuous drip infusion of low-dose etoposide and low-dose cytosine arabinoside combined with mitoxantrone (MEtA)].
    Tsukaguchi M; Furukawa Y; Shibano M; Kitani T
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1119-23. PubMed ID: 15272598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of topotecan-based combination therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Beran M; Kantarjian H
    Semin Hematol; 1999 Oct; 36(4 Suppl 8):3-10. PubMed ID: 10622223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [High-dose cytosine arabinoside treatment of leukemia with special reference to the optimal number of doses].
    Sampi K; Maseki N; Kumai R; Kaneko Y; Sakurai M; Hattori M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2595-8. PubMed ID: 2774589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].
    Rodríguez JN; Fernández-Jurado A; Martino ML; Diéguez JC; Moreno MV; Quesada JA; Polo B; Cañavate M; Amian A; Prados D
    Sangre (Barc); 1998 Feb; 43(1):35-9. PubMed ID: 9580427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All trans retinoic acid with low dose cytosine arabinoside in the treatment of myelodysplastic syndrome.
    Nair R; Nair CN; Advani SH
    Leuk Lymphoma; 1998 Mar; 29(1-2):187-92. PubMed ID: 9638988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytogenetic and clonal culture evaluation after response to low dose Ara-C in myelodysplastic syndromes.
    Hotta T; Goto S; Tsushita K; Kagami Y; Ohashi H; Ichikawa A; Ichihara M; Takagi N; Murate T; Yamao H
    Leukemia; 1991 Nov; 5(11):962-6. PubMed ID: 1961037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small-dose cytosine arabinoside in the treatment of elderly patients with acute leukemia and refractory anemia with excess of blast.
    Satou Y; Kubota T; Yonekura S; Noguchi K; Oobayashi Y; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1986 Oct; 11(4):249-54. PubMed ID: 3617109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of low-dose Ara-C regimen on myelodysplastic syndrome (MDS)].
    Kuriyama K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1198-204. PubMed ID: 3164177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemotherapy.
    Ito T; Ohashi H; Kagami Y; Ichikawa A; Saito H; Hotta T
    Leukemia; 1994 May; 8(5):839-43. PubMed ID: 7910221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A combination chemotherapy with low doses of cytarabine and etoposide for high risk myelodysplastic syndromes and their leukemic stage. A pilot study.
    Kuriya S; Murai K; Miyairi Y; Utsugisawa T; Narigasawa Y; Ito T; Shimosegawa K; Ishida Y
    Cancer; 1996 Aug; 78(3):422-6. PubMed ID: 8697386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idarubicin plus continuous-infusion high-dose cytarabine as treatment for patients with acute myelogenous leukemia or myelodysplastic syndrome.
    Estey EH; Kantarjian H; Keating M
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):1-5. PubMed ID: 8290966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.